Patents Assigned to Changzhou No. 4 Pharmaceutical Factory Co., Ltd
  • Patent number: 11801236
    Abstract: The present invention provides a method for improving the stability of pramipexole or its salt preparation, and further provides a pramipexole hydrochloride oral liquid with excellent stability and oral absorption effect. The pramipexole hydrochloride oral liquid of the present invention is prepared through a simple process, and shows bioequivalence with the tablet containing pramipexole hydrochloride. The invention perfectly realizes multi-dose administration of pramipexole hydrochloride and improves the compliance and accessibility of medication for patients.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: October 31, 2023
    Assignees: CHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO. LTD, BEIJING DO-PHARMA TECH CO. LTD
    Inventors: Xinhua Fan, Yanyuan Zhang, Yun He, Pengfei Li, Xiang Zhang, Longhao Wu, Peng Peng, Sujing Zhuang, Li Xiao, Yongrui Tu
  • Patent number: 9163058
    Abstract: A method as well as new intermediates for preparing Ulipristal acetate (a compound I) and a method for preparing the new intermediates are provided. The intermediate in a constitutional formula IV is conductive to reacting with methyl lithium or methyl Grignard reagent, a protective group is easy to be removed after a reaction, side reactions are few, a mid-term treatment is simple, the reagents used are cheap, costs are low and a yield is high, if a compound in a constitutional formula V is obtained by the reaction of a compound in a constitutional formula III and the intermediate in the constitutional formula IV, the yield of a two-step reaction is 75%, a purity is above 98%. wherein R is defined in the specification.
    Type: Grant
    Filed: July 12, 2012
    Date of Patent: October 20, 2015
    Assignees: Utopharm (Shanghai) Co., Ltd, Changzhou No. 4 Pharmaceutical Factory Co., Ltd
    Inventors: Junzhi Luo, Yongqiang Sun, Xun Luo, Yimin Yan, Zhaojun Wang, Mingxia Qian, Yongrui Tu